HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-APR-16 5J6A TITLE CRYSTAL STRUCTURE OF PYRUVATE DEHYDROGENASE KINASE ISOFORM 2 IN TITLE 2 COMPLEX WITH INHIBITOR PS46 COMPND MOL_ID: 1; COMPND 2 MOLECULE: [PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING)] KINASE COMPND 3 ISOZYME 2, MITOCHONDRIAL; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PYRUVATE DEHYDROGENASE KINASE ISOFORM 2,PDKII; COMPND 6 EC: 2.7.11.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDK2, PDHK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GHKL PROTEIN KINASE, PYRUVATE DEHYDROGENASE COMPLEX, MITOCHONDRIAL KEYWDS 2 PROTEIN KINASES, IMPAIRED GLUCOSE OXIDATION, HEPATIC STEATOSIS, TYPE KEYWDS 3 2 DIABETES, CANCER, BERGERAT NUCLEOTIDE-BINDING FOLD, PROTEIN KEYWDS 4 KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.J.GUI,S.C.TSO,J.L.CHUANG,C.Y.WU,X.QI,R.M.WYNN,D.T.CHUANG REVDAT 5 27-SEP-23 5J6A 1 REMARK REVDAT 4 25-DEC-19 5J6A 1 REMARK REVDAT 3 20-SEP-17 5J6A 1 REMARK REVDAT 2 22-FEB-17 5J6A 1 JRNL REVDAT 1 25-JAN-17 5J6A 0 JRNL AUTH S.C.TSO,M.LOU,C.Y.WU,W.J.GUI,J.L.CHUANG,L.K.MORLOCK, JRNL AUTH 2 N.S.WILLIAMS,R.M.WYNN,X.QI,D.T.CHUANG JRNL TITL DEVELOPMENT OF DIHYDROXYPHENYL SULFONYLISOINDOLINE JRNL TITL 2 DERIVATIVES AS LIVER-TARGETING PYRUVATE DEHYDROGENASE KINASE JRNL TITL 3 INHIBITORS. JRNL REF J. MED. CHEM. V. 60 1142 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28085286 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01540 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.C.TSO,X.QI,C.Y.WU,W.J.GUI,J.L.CHUANG,L.K.MORLOCK, REMARK 1 AUTH 2 N.S.WILLIAMS,R.M.WYNN,D.T.CHUANG REMARK 1 TITL DEVELOPMENT OF DIHYDROXYPHENYL SULFONYLISOINDOLINE-BASED REMARK 1 TITL 2 PYRUVATE DEHYDROGENASE KINASE INHIBITOR TARGETING LIVER OF REMARK 1 TITL 3 DIET-INDUCED OBESE MICE REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.9 REMARK 3 NUMBER OF REFLECTIONS : 34146 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.520 REMARK 3 FREE R VALUE TEST SET COUNT : 3308 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.5168 - 5.8873 0.96 2704 164 0.1881 0.2139 REMARK 3 2 5.8873 - 4.6778 0.99 2804 153 0.1730 0.1739 REMARK 3 3 4.6778 - 4.0880 0.99 2794 159 0.1468 0.1792 REMARK 3 4 4.0880 - 3.7148 0.99 2774 164 0.1658 0.1727 REMARK 3 5 3.7148 - 3.4489 0.99 2788 162 0.1785 0.2356 REMARK 3 6 3.4489 - 3.2458 0.99 2779 163 0.2001 0.2506 REMARK 3 7 3.2458 - 3.0834 0.99 2784 163 0.2132 0.2575 REMARK 3 8 3.0834 - 2.9493 0.99 2761 159 0.2230 0.2736 REMARK 3 9 2.9493 - 2.8358 0.99 2777 171 0.2127 0.2701 REMARK 3 10 2.8358 - 2.7380 0.99 2777 160 0.2105 0.2531 REMARK 3 11 2.7380 - 2.6524 0.98 2726 166 0.2168 0.2373 REMARK 3 12 2.6524 - 2.5767 0.98 2785 161 0.2186 0.2635 REMARK 3 13 2.5767 - 2.5089 0.98 2748 155 0.2116 0.2362 REMARK 3 14 2.5089 - 2.4477 0.98 2770 162 0.2101 0.2405 REMARK 3 15 2.4477 - 2.3920 0.97 2681 155 0.2125 0.2387 REMARK 3 16 2.3920 - 2.3412 0.87 2434 140 0.2167 0.2231 REMARK 3 17 2.3412 - 2.2943 0.73 2079 120 0.1911 0.2675 REMARK 3 18 2.2943 - 2.2511 0.64 1818 102 0.2152 0.2709 REMARK 3 19 2.2511 - 2.2109 0.58 1605 103 0.2341 0.2496 REMARK 3 20 2.2109 - 2.1734 0.54 1537 92 0.2443 0.2618 REMARK 3 21 2.1734 - 2.1383 0.52 1456 87 0.2264 0.3089 REMARK 3 22 2.1383 - 2.1055 0.52 1449 85 0.2407 0.3140 REMARK 3 23 2.1055 - 2.0745 0.50 1405 82 0.2646 0.2952 REMARK 3 24 2.0745 - 2.0453 0.48 1371 80 0.2654 0.2949 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2867 REMARK 3 ANGLE : 0.897 3895 REMARK 3 CHIRALITY : 0.053 429 REMARK 3 PLANARITY : 0.006 497 REMARK 3 DIHEDRAL : 13.864 1751 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J6A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000219878. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36197 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.045 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.230 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4MPN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM ACETATE PH 5.6 9% REMARK 280 ISOPROPANOL 100 MM MEGNESIUM CHLORIDE 50 MM AMMONIUM SULFATE, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.14000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 56.28000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 28.14000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.28000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -109.38900 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 8 REMARK 465 LYS A 9 REMARK 465 ASN A 10 REMARK 465 SER A 42 REMARK 465 ASN A 43 REMARK 465 ALA A 44 REMARK 465 GLY A 178 REMARK 465 SER A 179 REMARK 465 THR A 180 REMARK 465 ASN A 181 REMARK 465 PRO A 182 REMARK 465 ALA A 183 REMARK 465 HIS A 184 REMARK 465 PRO A 185 REMARK 465 LYS A 186 REMARK 465 ALA A 311 REMARK 465 PRO A 312 REMARK 465 THR A 313 REMARK 465 PRO A 314 REMARK 465 GLN A 315 REMARK 465 PRO A 316 REMARK 465 GLY A 317 REMARK 465 THR A 318 REMARK 465 GLY A 319 REMARK 465 GLY A 320 REMARK 465 THR A 321 REMARK 465 PRO A 322 REMARK 465 LEU A 323 REMARK 465 ALA A 324 REMARK 465 TYR A 374 REMARK 465 ASN A 375 REMARK 465 LYS A 376 REMARK 465 SER A 377 REMARK 465 ALA A 378 REMARK 465 TRP A 379 REMARK 465 ARG A 380 REMARK 465 HIS A 381 REMARK 465 TYR A 382 REMARK 465 GLN A 383 REMARK 465 THR A 384 REMARK 465 ILE A 385 REMARK 465 GLN A 386 REMARK 465 GLU A 387 REMARK 465 ALA A 388 REMARK 465 GLY A 389 REMARK 465 ASP A 390 REMARK 465 TRP A 391 REMARK 465 CYS A 392 REMARK 465 VAL A 393 REMARK 465 PRO A 394 REMARK 465 SER A 395 REMARK 465 THR A 396 REMARK 465 GLU A 397 REMARK 465 PRO A 398 REMARK 465 LYS A 399 REMARK 465 ASN A 400 REMARK 465 THR A 401 REMARK 465 SER A 402 REMARK 465 THR A 403 REMARK 465 TYR A 404 REMARK 465 ARG A 405 REMARK 465 VAL A 406 REMARK 465 SER A 407 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 34 O HOH A 601 2.16 REMARK 500 O HOH A 671 O HOH A 691 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 143 66.83 -108.34 REMARK 500 MET A 217 -24.59 82.43 REMARK 500 ASN A 231 75.68 -150.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P46 A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MP2 RELATED DB: PDB REMARK 900 4MP2 CONTAINS THESAME PROTEIN WITH DIFFERENT COMPOUND. REMARK 900 RELATED ID: 4MP7 RELATED DB: PDB REMARK 900 4MP7 CONTAINS THESAME PROTEIN WITH DIFFERENT COMPOUND. REMARK 900 RELATED ID: 4MPC RELATED DB: PDB REMARK 900 4MPC CONTAINS THESAME PROTEIN WITH DIFFERENT COMPOUND. REMARK 900 RELATED ID: 4MPE RELATED DB: PDB REMARK 900 4MPE CONTAINS THESAME PROTEIN WITH DIFFERENT COMPOUND. REMARK 900 RELATED ID: 4MPN RELATED DB: PDB REMARK 900 4MPN CONTAINS THESAME PROTEIN WITH DIFFERENT COMPOUND. REMARK 900 RELATED ID: 5J71 RELATED DB: PDB REMARK 900 5J71 CONTAINS THE SAME PROTEIN WITH DIFFERENT COMPOUND. DBREF 5J6A A 9 407 UNP Q15119 PDK2_HUMAN 9 407 SEQADV 5J6A SER A 8 UNP Q15119 EXPRESSION TAG SEQRES 1 A 400 SER LYS ASN ALA SER LEU ALA GLY ALA PRO LYS TYR ILE SEQRES 2 A 400 GLU HIS PHE SER LYS PHE SER PRO SER PRO LEU SER MET SEQRES 3 A 400 LYS GLN PHE LEU ASP PHE GLY SER SER ASN ALA CYS GLU SEQRES 4 A 400 LYS THR SER PHE THR PHE LEU ARG GLN GLU LEU PRO VAL SEQRES 5 A 400 ARG LEU ALA ASN ILE MET LYS GLU ILE ASN LEU LEU PRO SEQRES 6 A 400 ASP ARG VAL LEU SER THR PRO SER VAL GLN LEU VAL GLN SEQRES 7 A 400 SER TRP TYR VAL GLN SER LEU LEU ASP ILE MET GLU PHE SEQRES 8 A 400 LEU ASP LYS ASP PRO GLU ASP HIS ARG THR LEU SER GLN SEQRES 9 A 400 PHE THR ASP ALA LEU VAL THR ILE ARG ASN ARG HIS ASN SEQRES 10 A 400 ASP VAL VAL PRO THR MET ALA GLN GLY VAL LEU GLU TYR SEQRES 11 A 400 LYS ASP THR TYR GLY ASP ASP PRO VAL SER ASN GLN ASN SEQRES 12 A 400 ILE GLN TYR PHE LEU ASP ARG PHE TYR LEU SER ARG ILE SEQRES 13 A 400 SER ILE ARG MET LEU ILE ASN GLN HIS THR LEU ILE PHE SEQRES 14 A 400 ASP GLY SER THR ASN PRO ALA HIS PRO LYS HIS ILE GLY SEQRES 15 A 400 SER ILE ASP PRO ASN CYS ASN VAL SER GLU VAL VAL LYS SEQRES 16 A 400 ASP ALA TYR ASP MET ALA LYS LEU LEU CYS ASP LYS TYR SEQRES 17 A 400 TYR MET ALA SER PRO ASP LEU GLU ILE GLN GLU ILE ASN SEQRES 18 A 400 ALA ALA ASN SER LYS GLN PRO ILE HIS MET VAL TYR VAL SEQRES 19 A 400 PRO SER HIS LEU TYR HIS MET LEU PHE GLU LEU PHE LYS SEQRES 20 A 400 ASN ALA MET ARG ALA THR VAL GLU SER HIS GLU SER SER SEQRES 21 A 400 LEU ILE LEU PRO PRO ILE LYS VAL MET VAL ALA LEU GLY SEQRES 22 A 400 GLU GLU ASP LEU SER ILE LYS MET SER ASP ARG GLY GLY SEQRES 23 A 400 GLY VAL PRO LEU ARG LYS ILE GLU ARG LEU PHE SER TYR SEQRES 24 A 400 MET TYR SER THR ALA PRO THR PRO GLN PRO GLY THR GLY SEQRES 25 A 400 GLY THR PRO LEU ALA GLY PHE GLY TYR GLY LEU PRO ILE SEQRES 26 A 400 SER ARG LEU TYR ALA LYS TYR PHE GLN GLY ASP LEU GLN SEQRES 27 A 400 LEU PHE SER MET GLU GLY PHE GLY THR ASP ALA VAL ILE SEQRES 28 A 400 TYR LEU LYS ALA LEU SER THR ASP SER VAL GLU ARG LEU SEQRES 29 A 400 PRO VAL TYR ASN LYS SER ALA TRP ARG HIS TYR GLN THR SEQRES 30 A 400 ILE GLN GLU ALA GLY ASP TRP CYS VAL PRO SER THR GLU SEQRES 31 A 400 PRO LYS ASN THR SER THR TYR ARG VAL SER HET P46 A 501 35 HETNAM P46 (3S)-3-AMINO-4-[4-({2-[(2,4-DIHYDROXYPHENYL)SULFONYL]- HETNAM 2 P46 2H-ISOINDOL-5-YL}AMINO)PIPERIDIN-1-YL]-4-OXOBUTANAMIDE FORMUL 2 P46 C23 H27 N5 O6 S FORMUL 3 HOH *109(H2 O) HELIX 1 AA1 SER A 12 ALA A 14 5 3 HELIX 2 AA2 GLY A 15 SER A 24 1 10 HELIX 3 AA3 SER A 32 GLY A 40 1 9 HELIX 4 AA4 GLU A 46 ASN A 69 1 24 HELIX 5 AA5 PRO A 72 SER A 77 1 6 HELIX 6 AA6 THR A 78 GLU A 97 1 20 HELIX 7 AA7 ASP A 105 HIS A 123 1 19 HELIX 8 AA8 ASP A 125 TYR A 141 1 17 HELIX 9 AA9 ASP A 144 PHE A 176 1 33 HELIX 10 AB1 VAL A 197 MET A 217 1 21 HELIX 11 AB2 VAL A 241 HIS A 264 1 24 HELIX 12 AB3 PRO A 296 ARG A 298 5 3 HELIX 13 AB4 LYS A 299 PHE A 304 1 6 HELIX 14 AB5 GLY A 329 PHE A 340 1 12 SHEET 1 AA1 2 ASP A 192 ASN A 196 0 SHEET 2 AA1 2 HIS A 237 TYR A 240 -1 O TYR A 240 N ASP A 192 SHEET 1 AA2 5 LEU A 222 ASN A 228 0 SHEET 2 AA2 5 ILE A 273 LEU A 279 1 O VAL A 275 N GLU A 223 SHEET 3 AA2 5 ASP A 283 ASP A 290 -1 O SER A 289 N LYS A 274 SHEET 4 AA2 5 GLY A 353 LYS A 361 -1 O ALA A 356 N MET A 288 SHEET 5 AA2 5 ASP A 343 MET A 349 -1 N ASP A 343 O TYR A 359 SITE 1 AC1 15 LEU A 252 ASN A 255 ALA A 259 GLU A 262 SITE 2 AC1 15 SER A 263 GLU A 265 ASP A 290 GLY A 294 SITE 3 AC1 15 VAL A 295 THR A 354 HOH A 603 HOH A 609 SITE 4 AC1 15 HOH A 630 HOH A 639 HOH A 655 CRYST1 109.389 109.389 84.420 90.00 90.00 120.00 P 64 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009142 0.005278 0.000000 0.00000 SCALE2 0.000000 0.010556 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011846 0.00000